Back to top
more

Amedisys (AMED)

(Delayed Data from NSDQ)

$96.12 USD

96.12
370,120

+0.08 (0.08%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $96.15 +0.03 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 18% (45 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Amedisys (AMED) Earnings Expected to Grow: Should You Buy?

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Hospice Strength Show on Amedisys' (AMED) Q4 Earnings?

An increased reimbursement of approximately $1 million has boosted Amedisys' (AMED) Hospice business.

Medtronic Posts Prelim PRODIGY Outcome on Opioid Overdose

The favorable PRODIGY study result by Medtronic (MDT) is undoubtedly a timely, strategic finding.

Align Technology Unveils iTero Element 5D Imaging System

Align Technology (ALGN) continues to expand work flow options of iTero scanners.

Here's Why You Must Buy Cardiovascular Systems' (CSII) Stock

Cardiovascular Systems (CSII) has been firing on all cylinders of late to expand its geographical presence. The company is progressing well with its objective to introduce OAS globally.

Boston Scientific Benefits From New Buyouts & Product Launch

Boston Scientific's (BSX) closure of Millipede acquisition and its buyout agreement with BTG plc are major developments for the company.

Edwards Lifesciences to Buy CASMED to Boost Critical Care Arm

The CASMED buyout is expected to strengthen Edwards Lifesciences' (EW) position in smart monitoring technologies and boost top-line contributions from the Critical Care arm.

Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

Sector ETF report for PTH

Here's Why You Should Buy IDEXX Laboratories (IDXX) Stock

IDEXX (IDXX) continues to demonstrate solid growth globally, with strong international expansion.

Amedisys (AMED) Upgraded to Buy: What Does It Mean for the Stock?

Amedisys (AMED) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Chandrima Sanyal headshot

3 Investment Tips to Help You Achieve Your 2019 Goals

Here are a few ways to invest your money that will help you improve your financial health and mitigate the impacts of any potential adversity.

Amedisys (AMED) Gains But Lags Market: What You Should Know

Amedisys (AMED) closed the most recent trading day at $129.41, moving +1.47% from the previous trading session.

Illumina (ILMN) Q4 Earnings Lag Estimates, Revenues Top Mark

Illumina's (ILMN) Q4 figures show a sturdy uptick in sequencing consumable revenues.

ADUS vs. AMED: Which Stock Should Value Investors Buy Now?

ADUS vs. AMED: Which Stock Is the Better Value Option?

Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?

Is (AMED) Outperforming Other Medical Stocks This Year?

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

Here's Why You Should Snap Up Abbott (ABT) Stock Right Now

We are optimistic about the strong and consistent performance of Abbott's (ABT) EPD segment. The company's Diabetes Care business has been hogging the limelight on strength in FreeStyle Libre.

Thermo Fisher (TMO) Down on Business Divestment Declaration

Thermo Fisher's (TMO) Anatomical Pathology business comes under its Specialty Diagnostics segment catering to customers at healthcare and clinical laboratories.

Here's Why You Should Buy Tandem Diabetes (TNDM) Stock Now

Strength in domestic sales along with the recent launch of the t:slim X2 Insulin Pump in selected international markets bode well for Tandem Diabetes (TNDM).

Zacks.com featured expert Kevin Matras highlights: Caseys General Stores, Shoe Carnival, Amedisys, Expeditors International of Washington and Stitch Fix

Zacks.com featured expert Kevin Matras highlights: Caseys General Stores, Shoe Carnival, Amedisys, Expeditors International of Washington and Stitch Fix

Henry Schein Animal Health Spin-Off Approaches, Costs Mount (revised)

Henry Schein's (HSIC) animal health spin-off will help it boost growth opportunities in dental space to deliver quality clinical care plus advanced wellness and prevention.

Sanghamitra Saha headshot

Bet on DuPont Analysis: Play 5 Quality Stocks

Bet on five top-ranked stocks with higher ROE derived the DuPont way.

Quest Diagnostics' Core Diagnostics Strong Amid Several Woes

Quest Diagnostics' (DGX) steady efforts to intensify focus on core diagnostic information services business and an intelligent capital management give investors ample reasons to cheer for.

Amedisys (AMED) Gains But Lags Market: What You Should Know

Amedisys (AMED) closed at $127 in the latest trading session, marking a +0.09% move from the prior day.

Can Medical Devices Strength Drive Abbott (ABT) Q4 Earnings?

Abbott (ABT) Q4 results likely to show continued growth in Medical Devices business.